Personalized Medicine: Insurance and Reimbursement Policies in South Asia.

Genomic MedicineInsurance PoliciesPersonalized MedicinePrecision MedicineSouth Asia Healthcarereimbursement framework

The report provides a comprehensive analysis of personalized medicine, focusing on insurance and reimbursement policies within South Asia. It highlights the challenges and opportunities posed by precision medicine and genomic-based care, emphasizing the need for equitable access and sustainable integration into healthcare systems. The document explores regional healthcare structures, policy frameworks, and the economic impact of precision medicine. It also offers strategic recommendations for policymakers, insurers, and healthcare providers to enhance the adoption and effectiveness of personalized medicine in the region.

Researcher

Vivek Goswami, Ghost Research

PublishedNovember 2025

Perspective.

PurposeTo analyze and provide strategic insights on the integration of personalized medicine into South Asian healthcare systems, focusing on insurance and reimbursement policies.

AudienceHealthcare stakeholders, policymakers, insurance companies, and medical providers in South Asia.

Special EmphasisEmphasis on innovation, policy development, and equitable access.

52Pages of Deep Analysis

124Curated Credible Sources

1Proprietary AI Visuals

1Data Analysis Tables

$495

Vivek Goswami

11+ Years of Experience

Sectors & Industries

IndustrialsConsumer StaplesEnergy

Functions & Expertise

Market IntelligenceStrategy & GTM

Have questions? Our Research Desk is here to help

Top Insights.

Precision medicine is rapidly transforming healthcare in South Asia with significant potential for growth.Regional disparities in access and infrastructure limit the widespread adoption of personalized medicine.There is a critical need for harmonized policies and regulatory frameworks to ensure equitable access.Innovative insurance models and reimbursement strategies are essential for affordability and scalability.Public-private partnerships play a crucial role in advancing precision medicine initiatives.

Key Questions Answered.

52Pages of Deep Analysis

1Proprietary AI Visuals

124Curated Credible Sources

1Data Analysis Tables

Summary.

Precision medicine in South Asia is projected to grow from $40.44 billion in 2024 to $158.92 billion by 2034, driven by innovations in genomics and AI. However, significant disparities exist due to high costs and infrastructure gaps, with rural and low-income communities facing barriers to access.

To improve equity, policymakers are urged to adopt targeted strategies, including investing in digital infrastructure and fostering public-private partnerships. AI-driven diagnostics and mRNA therapies are emerging technologies that promise to revolutionize patient care, potentially driving $1.615 trillion in economic benefits across Asia-Pacific.

Personalized Medicine: Insurance and Reimbursement Policies in South Asia.

Perspective.

Vivek Goswami

1What is the primary goal of the report?

2Who is the intended audience for this report?

3What are the main barriers to precision medicine adoption in the region?

4How does the report suggest improving access to precision medicine?

5What role do public-private partnerships play in the report's recommendations?

Summary.